martes, 25 de octubre de 2011

PSA test valuable in predicting biopsy need lowrisk prostate cancer

The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, Calif.

Via: http://medicalxpress.com

No hay comentarios: